These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18323273)

  • 1. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
    Grefte JM; de Wilde PC; Salet-van de Pol MR; Tomassen M; Raaymakers-van Geloof WL; Bulten J
    Acta Cytol; 2008; 52(1):35-44. PubMed ID: 18323273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA.
    Stoop JA; Hendriks JG; Berends D
    Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
    Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
    Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
    Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
    Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.
    Politi E; Kandaraki C; Apostolopoulou C; Kyritsi T; Koutselini H
    Diagn Cytopathol; 2005 Mar; 32(3):151-5. PubMed ID: 15690338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction between cells in serous effusions using a panel of antibodies.
    Lauritzen AF
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody.
    Donna A; Betta PG; Bellingeri D; Tallarida F; Pavesi M; Pastormerlo M
    Diagn Cytopathol; 1992; 8(4):361-5. PubMed ID: 1638937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center.
    Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S
    Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions.
    Khurram N; Anis T; Yusuf NW
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing.
    Kuenen-Boumeester V; van Loenen P; de Bruijn EM; Henzen-Logmans SC
    Acta Cytol; 1996; 40(3):475-9. PubMed ID: 8669182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.
    Gong Y; Sun X; Michael CW; Attal S; Williamson BA; Bedrossian CW
    Diagn Cytopathol; 2003 Jan; 28(1):1-5. PubMed ID: 12508174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of immunocytochemistry in differential diagnosis of gastric adenocarcinoma, reactive mesothelial cells and malignant epithelial mesothelioma in metastatic effusion fluid].
    Lyu M; Cha N; Zou YF; Leng JH; Xu L; Sun Y; Hao YY
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):180-185. PubMed ID: 29534357
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.
    Ueda J; Iwata T; Ono M; Takahashi M
    Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.